BioSpace News Archive

Policy

Difficulties in Approving Depression Drugs Highlighted This Week

One of the drugs being discussed this week by a U.S. Food and Drug Administration advisory committee is Waltham, Mass.-based Alkermes’ ALKS-5461. The drug itself has some controversy.

October 31, 2018
·
4 min read
·
Mark Terry
Business

Will GSK Move Away from Respiratory Treatments for a Focus on Oncology R&D?

In an interview with S&P Global Market Intelligence, Alex Hoos, head of oncology at GSK, said the company could narrow its drug development focus to aim at products that will generate growth.

October 31, 2018
·
3 min read
·
Alex Keown
FDA

FDA Greenlights Another Indication for Merck’s Keytruda

Merck’s blockbuster anti-PD-1 therapy Keytruda has snagged another regulatory approval from the U.S. Food and Drug Administration. The checkpoint inhibitor has been approved, in combination with chemotherapy, as a first-line treatment for patients with metastatic squamous non-small cell lung cancer.

October 31, 2018
·
2 min read
·
Alex Keown
Job Trends

Biotech Hires Go Beyond Lab Scientists, Report Shows

Biotech companies need more than just researchers to ensure success. The most recent 2018 Talent Report issued by Biocom shows that 88 percent of California life science companies are planning on hiring over the next 12 months.

October 31, 2018
·
2 min read
·
Alex Keown
Policy

FDA, DHS Strengthen Collaboration Against Medical Device Cybersecurity Threats

The U.S. Food and Drug Administration (FDA) and Department of Homeland Security (DHS) are celebrating National Cybersecurity Awareness Month by announcing a strengthened partnership to buff up medical device cybersecurity, increasing communication and coordination between the two agencies.

October 31, 2018
·
4 min read
·
Chelsea Weidman Burke
Business

It Takes Two: Gilead and Tango Partner on Immuno-Oncology

The deal, which will last several years, has Tango performing target discovery and validation. Gilead will be able to option rights to up to five targets that come out of Tango’s work.

October 31, 2018
·
2 min read
·
Mark Terry
Deals

Updated: BioSpace’s List of November 2018 Life Sciences IPOs

A summary of IPOs from companies in the biotech and pharma world since November 1, 2018.

October 31, 2018
·
1 min read
·
Editorial Staff
Drug Development

Can a Pharma Drug Improve Autism Conditions?

There are no treatments for autism, but that’s not stopping research into the development of therapies for core symptoms of autism spectrum disorder. This week, London-based AMO Pharma reported Phase II results from its investigational glycogen synthase kinase 3 (GSK3) beta inhibitor, AMO-02 (tideglusib).

October 31, 2018
·
3 min read
·
Alex Keown
Top 12 Life Science Companies Hiring Now

Fall is in full swing, but not falling short of jobs. Check out the top companies who are looking for candidates like you right now!

October 31, 2018
·
1 min read
·
Editorial Staff
A Dirty Dozen Pieces of Career Advice From the Best Bosses

With any luck, each job will have great bosses, as unlikely as that seems. But even if your bosses aren’t necessarily great, you can probably learn something from each of them. Here are a dozen lessons you can learn from the best bosses.

October 31, 2018
·
4 min read
·
Mark Terry